| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.23 | 6e-05 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0004 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.16 | 0.0006 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.004 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.005 |